Health
Cancer Vaccine Shows Promising Results in Clinical Trials
A personalized mRNA cancer vaccine has shown significant promise, reducing the risk of disease recurrence by 42% in patients with melanoma compared to standard treatments. The breakthrough could lead to more effective immunotherapies for various cancers.
Coverage timeline — 1 article
STAT News
A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment
2026-10-23 13:45 UTC